Metabolomic profiles associated with bone mineral density in US Caucasian women

Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006;38:S4–9.

Atik OS, Gunal I, Korkusuz F. Burden of osteoporosis. Clin Orthop Relat Res. 2006;443:19–24.

Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr Rheumatol Rep. 2008;10:92–6.

Drake MT, Clarke BL, Lewiecki EM. The pathophysiology and treatment of osteoporosis. Clin Ther. 2015;37:1837–50.

Silverman SL, Calderon AD. The utility and limitations of FRAX: a US perspective. Curr Osteoporos Rep. 2010;8:192–7.

Curtis EM, Moon RJ, Dennison EM, Harvey NC, Cooper C. Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med (Lond). 2016;16:360–4.

Johnson CH, Ivanisevic J, Siuzdak G. Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016;17:451–9.

You YS, Lin CY, Liang HJ, Lee SH, Tsai KS, Chiou JM, Chen YC, et al. Association between the metabolome and low bone mineral density in Taiwanese women determined by (1)H NMR spectroscopy. J Bone Miner Res. 2014;29:212–22.

Qi H, Bao J, An G, Ouyang G, Zhang P, Wang C, Ying H, et al. Association between the metabolome and bone mineral density in pre- and post-menopausal Chinese women using GC-MS. Mol BioSyst. 2016;12:2265–75.

Miyamoto T, Hirayama A, Sato Y, Koboyashi T, Katsuyama E, Kanagawa H, Miyamoto H, et al. A serum metabolomics-based profile in low bone mineral density postmenopausal women. Bone. 2017;95:1–4.

Moayyeri A, Cheung CL, Tan KC, Morris JA, Cerani A, Mohney RP, Richards JB, et al. Metabolomic pathways to osteoporosis in middle-aged women: a genome-metabolome-wide Mendelian randomization study. J Bone Miner Res. 2018;33:643–50.

Liu L, Wen Y, Zhang L, Xu P, Liang X, Du Y, Li P, et al. Assessing the associations of blood metabolites with osteoporosis: a Mendelian randomization study. J Clin Endocrinol Metab. 2018;103:1850–55.

Yu B, Zheng Y, Alexander D, Morrison AC, Coresh J, Boerwinkle E. Genetic determinants influencing human serum metabolome among African Americans. PLoS Genet. 2014;10:e1004212.

Auro K, Joensuu A, Fischer K, Kettunen J, Salo P, Mattsson H, Niironen M, et al. A metabolic view on menopause and ageing. Nat Commun. 2014;5:4708.

Hernandez CJ, Beaupre GS, Carter DR. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int. 2003;14:843–7.

Hui SL, Slemenda CW, Johnston CC Jr. The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int. 1990;1:30–4.

He H, Liu Y, Tian Q, Papasian CJ, Hu T, Deng HW. Relationship of sarcopenia and body composition with osteoporosis. Osteoporos Int. 2016;27:473–82.

Du Y, Zhao LJ, Xu Q, Wu KH, Deng HW. Socioeconomic status and bone mineral density in adults by race/ethnicity and gender: the Louisiana osteoporosis study. Osteoporos Int. 2017;28:1699–709.

https://www.choosemyplate.gov/dairy . Last accessed 10 Jul 2018.

Liu H, Garrett TJ, Su Z, Khoo C, Gu L. UHPLC-Q-Orbitrap-HRMS-based global metabolomics reveal metabolome modifications in plasma of young women after cranberry juice consumption. J Nutr Biochem. 2017;45:67–76.

Pluskal T, Castillo S, Villar-Briones A, Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 2010;11:395.

Stekhoven DJ, Buhlmann P. MissForest--non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112–8.

Xi B, Gu H, Baniasadi H, Raftery D. Statistical analysis and modeling of mass spectrometry-based metabolomics data. Methods Mol Biol. 2014;1198:333–53.

Palermo G, Piraino P, Zucht HD. Performance of PLS regression coefficients in selecting variables for each response of a multivariate PLS for omics-type data. Adv Appl Bioinform Chem. 2009;2:57–70.

Gromski PS, Muhamadali H, Ellis DI, Xu Y, Correa E, Turner ML, Goodacre R. A tutorial review: metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding. Anal Chim Acta. 2015;879:10–23.

Xia J, Wishart DS. Using metaboanalyst 3.0 for comprehensive metabolomics data analysis. Curr Protoc Bioinformatics. 2016;55:14 0 1–0 91.

Jennings A, MacGregor A, Spector T, Cassidy A. Amino acid intakes are associated with bone mineral density and prevalence of low bone mass in women: evidence from discordant monozygotic twins. J Bone Miner Res. 2016;31:326–35.

Takahata Y, Takarada T, Hinoi E, Nakamura Y, Fujita H, Yoneda Y. Osteoblastic gamma-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor kappaB ligand in mouse bone. J Biol Chem. 2011;286:32906–17.

Han NR, Kim NR, Kim HM, Jeong HJ. Cysteine prevents menopausal syndromes in Ovariectomized mouse. Reprod Sci. 2016;23:670–9.

Choi MJ, Chang KJ, Lee JW, Jung YJ. Beneficial function of taurine on bone metabolism in alcohol-fed OVX rat model. Adv Exp Med Biol. 2017;975:1059–69.

Spencer GJ, McGrath CJ, Genever PG. Current perspectives on NMDA-type glutamate signalling in bone. Int J Biochem Cell Biol. 2007;39:1089–104.

Muhammad SI, Maznah I, Mahmud R, Zuki AB, Imam MU. Upregulation of genes related to bone formation by gamma-amino butyric acid and gamma-oryzanol in germinated brown rice is via the activation of GABAB-receptors and reduction of serum IL-6 in rats. Clin Interv Aging. 2013;8:1259–71.

Skerry TM. Identification of novel signaling pathways during functional adaptation of the skeleton to mechanical loading: the role of glutamate as a paracrine signaling agent in the skeleton. J Bone Miner Metab. 1999;17:66–70.

Yamada M, Tsukimura N, Ikeda T, Sugita Y, Att W, Kojima N, Kubo K, et al. N-acetyl cysteine as an osteogenesis-enhancing molecule for bone regeneration. Biomaterials. 2013;34:6147–56.

Choi MJ. Effects of taurine supplementation on bone mineral density in ovariectomized rats fed calcium deficient diet. Nutr Res Pract. 2009;3:108–13.

Sabour H, Nazari M, Latifi S, Soltani Z, Shakeri H, Larijani B, Ghodsi SM, et al. The relationship between dietary intakes of amino acids and bone mineral density among individuals with spinal cord injury. Oman Med J. 2016;31:22–8.

Nam SY, Yoou MS, Kim HM, Jeong HJ. Efficacy of proline in the treatment of menopause. Exp Biol Med (Maywood). 2016;241:611–9.

Michalowska M, Znorko B, Kaminski T, Oksztulska-Kolanek E, Pawlak D. New insights into tryptophan and its metabolites in the regulation of bone metabolism. J Physiol Pharmacol. 2015;66:779–91.

Dubreuil M, Ruiz-Gaspa S, Guanabens N, Peris P, Alvarez L, Monegal A, Combalia A, et al. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells. Liver Int. 2013;33:1029–38.

Hanly R, Ryan N, Snelling H, Walker-Bone K, Dizdarevic S, Peters AM. Association between bile acid turnover and osteoporosis in postmenopausal women. Nucl Med Commun. 2013;34:597–600.

Sims SM, Panupinthu N, Lapierre DM, Pereverzev A, Dixon SJ. Lysophosphatidic acid: a potential mediator of osteoblast-osteoclast signaling in bone. Biochim Biophys Acta. 2013;1831:109–16.

David M, Machuca-Gayet I, Kikuta J, Ottewell P, Mima F, Leblanc R, Bonnelye E, et al. Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity. J Biol Chem. 2014;289:6551–64.

Orosa B, Martinez P, Gonzalez A, Guede D, Caeiro JR, Gomez-Reino JJ, Conde C. Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice. J Bone Miner Metab. 2015;33:383–91.

Lane RK, Hilsabeck T, Rea SL. The role of mitochondrial dysfunction in age-related diseases. Biochim Biophys Acta. 2015;1847:1387–400.

Quelch KJ, Cole WG, Melick RA. Noncollagenous proteins in normal and pathological human bone. Calcif Tissue Int. 1984;36:545–9.

Mbuyi-Muamba JM, Gevers G, Dequeker J. Studies on EDTA extracts and collagenase digests from osteoporotic cancellous bone of the femoral head. Clin Biochem. 1987;20:221–4.